References
- Arima M, Kanoh T, Suzuki T, et al. Serial angiographic follow-up beyond 10 years after coronary artery bypass grafting. Circ J 2005;69:896–902
- Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97:916–931
- Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986;314:488–500
- Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788–791
- Nakahara T, Moroi Y, Uchi H, Furue M. Differentialrole of MAPK signaling in human dendritic cell maturation and Th1/Th2 engagement. J Dermatol Sci 2006;42:1–11
- Bobryshev YV. Dendritic cells and their role in atherogenesis. Lab Invest 2010;90:970–984
- Land W. Innate alloimmunity: history and current knowledge. Exp Clin Transplant 2007;5:575–584
- Saunders PC, Pintucci G, Bizekis CS, et al. Vein graft arterialization causes differential activation of mitogen-activated protein kinases. J Thorac Cardiovasc Surg 2004;127:1276–1284
- Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999;79:143–180
- Lille S, Daum G, Clowes MM, Clowes AW. The regulation of p42/p44 mitogen-activated protein kinases in the injured rat carotid artery. J Surg Res 1997;70:178–186
- Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37–40
- Koeberle SC, Romir J, Fischer S, et al. Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. Nat Chem Biol 2011;8:141–143
- Zou Y, Dietrich H, Hu Y, et al. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301–1310
- Pintucci G, Saunders PC, Gulkarov I, et al. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts. FASEB J 2006;20:398–400
- Mayr M, Li C, Zou Y, et al. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000;14:261–270
- Zou Y, Hu Y, Metzler B, Xu Q. Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review). Int J Mol Med 1998;1:827–834
- Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994;12:991–1045
- Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995;9:899–909
- Kim CJ, Khoo JC, Gillotte-Taylor K, et al. Polymerase chain reaction-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tumor necrosis factor-alpha and interleukin-1 beta. Arterioscler Thromb Vasc Biol 2000;20:1976–1982
- Loth F, Jones SA, Zarins CK, et al. Relative contribution of wall shear stress and injury in experimental intimal thickening at PTFE end-to-side arterial anastomoses. J Biomech Eng 2002;124:44–51
- Owens CD, Rybicki FJ, Wake N, et al. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation. J Vasc Surg 2008;47:1235–1242
- Ma X, Jia YT, Qiu DK. Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: involvement of nuclear factor kappa B. World J Gastroenterol 2007;13:4249–4254